Design Therapeutics, Inc. DSGN Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$69.71M+0.1% | -$69.79M-3.5% | -$67.45M-6.2% | -$63.49M-13.0% | -$56.2M-13.3% | ||
| $620K-0.3% | $622K+1.1% | $615K+0.3% | $613K+0.2% | $612K+2.7% | ||
| $14.93M+2.6% | $14.55M-0.2% | $14.59M+3.3% | $14.11M+5.1% | $13.43M+2.7% | ||
| -$54M+0.7% | -$54.36M-4.0% | -$52.25M-3.2% | -$50.64M-6.7% | -$47.46M-10.1% | ||
| $121K-37.3% | $193K— | —— | —— | —— | ||
| —— | —— | $36.33M— | —— | —— | ||
| $45.65M+77.4% | $25.74M+3,663% | $684K+5.6% | $648K+25.6% | $516K+0.6% | ||
| —— | —— | —— | —— | —— | ||
| -$54.12M+0.8% | -$54.55M-4.1% | -$52.41M-3.2% | -$50.78M-6.5% | -$47.67M-9.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Design Therapeutics, Inc. generate?
- Design Therapeutics, Inc. (DSGN) generated -$54.0M in operating cash flow over the trailing twelve months.
- What is Design Therapeutics, Inc.'s free cash flow?
- After $121.0K of capital expenditures, Design Therapeutics, Inc.'s free cash flow was -$54.1M over the trailing twelve months, down 13.5% year over year.
- Where does Design Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Design Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.